doi: 10.1373/clinchem.2004.037689.
Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor
- PMID: 15502102
- DOI: 10.1373/clinchem.2004.037689
Item in Clipboard
Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor
Clin Chem.
2004 Nov.
No abstract available
Comment in
-
Hypertriglyceridemia: interaction between APOE and APOAV variants.Clin Chem. 2005 Jul;51(7):1311-3. doi: 10.1373/clinchem.2005.048439. Clin Chem. 2005. PMID: 15976129 No abstract available.
-
Apolipoprotein A5 S19W may play a role in dysbetalipoproteinemia in patients with the Apo E2/E2 genotype.Clin Chem. 2006 Oct;52(10):1974-5. doi: 10.1373/clinchem.2006.070318. Clin Chem. 2006. PMID: 16998123 No abstract available.
Similar articles
-
Hypertriglyceridemia: interaction between APOE and APOAV variants.Clin Chem. 2005 Jul;51(7):1311-3. doi: 10.1373/clinchem.2005.048439. Clin Chem. 2005. PMID: 15976129 No abstract available.
-
Apolipoprotein A5 S19W may play a role in dysbetalipoproteinemia in patients with the Apo E2/E2 genotype.Clin Chem. 2006 Oct;52(10):1974-5. doi: 10.1373/clinchem.2006.070318. Clin Chem. 2006. PMID: 16998123 No abstract available.
-
Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia.Clin Genet. 2005 Oct;68(4):369-72. doi: 10.1111/j.1399-0004.2005.00510.x. Clin Genet. 2005. PMID: 16143024
-
Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants.Clin Chem Lab Med. 2005;43(9):897-902. doi: 10.1515/CCLM.2005.153. Clin Chem Lab Med. 2005. PMID: 16176166 Review.
-
Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?Ann Med. 2006;38(1):2-10. doi: 10.1080/07853890500407488. Ann Med. 2006. PMID: 16448983 Review.
Cited by
-
Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology.Gene. 2016 Oct 30;592(1):193-199. doi: 10.1016/j.gene.2016.07.070. Epub 2016 Aug 2. Gene. 2016. PMID: 27496343 Free PMC article. Review.
-
Phenotypic severity in a family with MEND syndrome is directly associated with the accumulation of potentially functional variants of cholesterol homeostasis genes.Mol Genet Genomic Med. 2019 Sep;7(9):e931. doi: 10.1002/mgg3.931. Epub 2019 Aug 8. Mol Genet Genomic Med. 2019. PMID: 31397093 Free PMC article.
-
The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.Eur J Hum Genet. 2009 May;17(5):620-8. doi: 10.1038/ejhg.2008.202. Epub 2008 Nov 26. Eur J Hum Genet. 2009. PMID: 19034316 Free PMC article.
-
Allelic drop-out may occur with a primer binding site polymorphism for the commonly used RFLP assay for the -1131T>C polymorphism of the Apolipoprotein AV gene.Lipids Health Dis. 2006 May 2;5:11. doi: 10.1186/1476-511X-5-11. Lipids Health Dis. 2006. PMID: 16670016 Free PMC article.
-
Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the apolipoprotein A5 gene.Eur J Med Res. 2011 Feb 24;16(2):79-84. doi: 10.1186/2047-783x-16-2-79. Eur J Med Res. 2011. PMID: 21463987 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
